| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3.03% | 11.81% | 71.19% | 27/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 1.77% | -89.75% | -67.04% | 43/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 5.37% | -57.18% | 18.81% | 32/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 4.52% | -38.17% | 66.79% | 26/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 2.71% | -27.54% | -84.3% | 26/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 17.26% | -4.11% | 37.64% | 6/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 12.54% | 3.38% | 71.55% | 11/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 7.31% | -3.05% | 95.45% | 15/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 3.74% | -13.82% | -79.22% | 18/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 18% | 4.9% | 48.39% | 7/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 12.13% | 27.28% | 60.88% | 13/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 7.54% | 31.59% | 73.73% | 15/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 4.34% | 127.23% | -74.71% | 18/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 17.16% | 25.9% | 80.06% | 7/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 9.53% | -15.51% | 66.32% | 20/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 5.73% | 1.6% | 200% | 20/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.91% | -19.07% | -85.99% | 38/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 13.63% | 24.7% | 20.83% | 12/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 11.28% | 102.51% | 100% | 14/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 5.64% | -12.01% | 138.98% | 23/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.36% | -43.68% | -78.41% | 35/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 10.93% | -51.51% | 96.23% | 18/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 5.57% | 2% | -13.1% | 37/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 6.41% | -35.51% | 52.98% | 14/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 4.19% | -27.13% | -81.41% | 8/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 22.54% | 23.44% | 126.76% | 5/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-06-30 | 9.94% | 15.18% | -45.56% | 3/68 | 4.75% | 济川药业 | 7.33% | 行业排名> |
| 2018-12-31 | 18.26% | 12.65% | 111.59% | 7/68 | 7.89% | 济川药业 | 27.43% | 行业排名> |
| 2018-06-30 | 8.63% | 53.56% | 50.09% | 6/68 | 5.05% | 济川药业 | 23.05% | 行业排名> |
| 2018-03-31 | 5.75% | 2% | -64.53% | 4/68 | 2.78% | 济川药业 | 15.79% | 行业排名> |
| 2017-12-31 | 16.21% | -13.13% | 188.43% | 10/68 | 9.95% | 华润三九 | 10.23% | 行业排名> |
| 2017-06-30 | 5.62% | -45.86% | -69.88% | 29/68 | 5.23% | 济川药业 | 32.79% | 行业排名> |
| 2016-12-31 | 18.66% | -29.93% | 79.77% | 8/68 | 10.19% | 济川药业 | 27.55% | 行业排名> |
| 2016-06-30 | 10.38% | -34.47% | -61.02% | 5/68 | 5.15% | 济川药业 | 17.62% | 行业排名> |

微信公众号
证券之星APP


